TiumBio Co., Ltd. (KOSDAQ:321550)

South Korea · Delayed Price · Currency is KRW

7,650.00

+500.00 (6.99%)

At close: Mar 13, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Pharmaceuticals	6.79B	4.90B	9.12B	56.80M	1.05B
Pharmaceuticals Growth	38.65%	-46.27%	15952.75%	-94.59%	-5.75%
Total	6.79B	4.90B	9.12B	56.80M	1.05B
Total Growth	38.65%	-46.27%	15952.75%	-94.59%	-5.75%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
South Korea	6.79B	4.90B	1.10B	56.80M	1.05B
South Korea Growth	38.65%	343.68%	1843.94%	-94.59%	-5.75%
Foreign	-	-	8.01B	-	-
Total	6.79B	4.90B	9.12B	56.80M	1.05B
Total Growth	38.65%	-46.27%	15952.63%	-94.59%	-5.75%

Source: S&P Global Market Intelligence.